Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women

NCT05318144 is registered in ClinicalTrials.gov with Nazan Yurtcu MD as lead sponsor.

NCT NCT05318144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05318144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women
Lead sponsor
Nazan Yurtcu MD
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
February 1, 2022
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute respiratory distress syndrome, pregnancy complications, pregnancy related